Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Chubb
Colorcon
Citi
Dow
Harvard Business School
Queensland Health
US Army
Deloitte
McKesson

Generated: August 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: oritavancin diphosphate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
The Medicines Co
ORBACTIV
oritavancin diphosphate
POWDER;IV (INFUSION)206334NDAThe Medicines Company65293-015-033 VIAL, GLASS in 1 CARTON (65293-015-03) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (65293-015-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Citi
Daiichi Sankyo
Express Scripts
Harvard Business School
Moodys
US Department of Justice
Fish and Richardson
UBS
Accenture

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot